Cargando…

Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test

Antiepileptic drugs (AEDs) can induce severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. We performed HLA genotyping and lymphocyte activation tests (LATs) fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun-Young, Kim, Mi-Yeong, Park, Chan Sun, Choi, Jae-Hyeog, Ghim, Jong-Lyul, Kim, Ho-Sook, Shin, Jae-Gook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989248/ https://www.ncbi.nlm.nih.gov/pubmed/32055583 http://dx.doi.org/10.12793/tcp.2019.27.2.64

Ejemplares similares

Allopurinol-induced severe cutaneous adverse reactions: A report of three cases with the HLA-B(*)58:01 allele who underwent lymphocyte activation test
por: Kim, Eun-Young, et al.
Publicado: (2017)

Associations between HLA-A, -B, and -C alleles and iodinated contrast media–induced hypersensitivity in Koreans
por: Kim, Eun-Young, et al.
Publicado: (2021)

Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs
por: Zhang, Jingang, et al.
Publicado: (2018)

HLA-B(*)13:01 as a Risk Allele for Antiepileptic Drugs-Induced Cutaneous Adverse Reactions: Higher Risk for Cross-Reactivity?
por: Min, Fu-Li, et al.
Publicado: (2019)

Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea
por: Park, Chan Sun, et al.
Publicado: (2019)

Association Between HLA Genotype and Cutaneous Adverse Reactions to Antiepileptic Drugs Among Epilepsy Patients in Northwest China
por: Wang, Xu, et al.
Publicado: (2019)

HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions
por: Shi, Yi-Wu, et al.
Publicado: (2017)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
por: Koch, Tina, et al.
Publicado: (2016)

Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions
por: Ahmed, Ali Fadhel, et al.
Publicado: (2021)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017)

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions
por: Wattanachai, Pansakon, et al.
Publicado: (2023)

HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema
por: Shi, Yi-Wu, et al.
Publicado: (2021)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
por: Oh, Minkyung, et al.
Publicado: (2018)

Antiepileptic Drug-Related Adverse Reactions and Factors Influencing These Reactions
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008–2017
por: Kim, Hyun Kyung, et al.
Publicado: (2019)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
por: Jantararoungtong, Thawinee, et al.
Publicado: (2014)

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2022)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects
por: Oh, Minkyung, et al.
Publicado: (2023)

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
por: Wu, Ran, et al.
Publicado: (2016)

Association between HLA-B*1502 allele and aromatic antiepileptic drugs-induced hypersensitivity syndrome reactions and the HLA-B*15:02 pharmacogenetics screening in autistic spectrum disorder
por: Sukasem, Chonlaphat, et al.
Publicado: (2014)

Pharmacokinetic study of metformin to compare a voglibose/metformin fixed-dose combination with coadministered voglibose and metformin
por: Choi, Hyang-Ki, et al.
Publicado: (2015)

Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis
por: Sukasem, Chonlaphat, et al.
Publicado: (2021)

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

Comparison between the HLA-B(∗)58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
por: Saksit, Niwat, et al.
Publicado: (2017)

A prospective study of adverse drug reactions to antiepileptic drugs in children
por: Anderson, Mark, et al.
Publicado: (2015)

Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions
por: Ramsbottom, Kerry A., et al.
Publicado: (2018)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
por: González-Galarza, Faviel F., et al.
Publicado: (2014)

Absence of HLA-B(*)1502 and HLA-A(*)3101 Alleles in 9 Korean Patients With Antiepileptic Drug-Induced Skin Rash: A Preliminary Study
por: Song, Ju Sun, et al.
Publicado: (2014)

Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B(*)58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
por: Nguyen, Dinh Van, et al.
Publicado: (2017)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
por: Oh, Minkyung, et al.
Publicado: (2017)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
por: Oh, Minkyung, et al.
Publicado: (2019)

Predominant HLA Alleles and Haplotypes in Mild Adverse Drug Reactions Caused by Allopurinol in Vietnamese Patients with Gout
por: Van Son, Chu, et al.
Publicado: (2021)

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
por: Sukasem, Chonlaphat, et al.
Publicado: (2018)

HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs
por: Park, Hye Jung, et al.
Publicado: (2016)

An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese
por: Jiang, Menglin, et al.
Publicado: (2023)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
por: Ghim, Jong-Lyul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9nt43c3rj7gu3t7rbrmtsab16j